Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dengue Virus Vaccine (SET Technology)
- Development stage
- Preclinical
- Lead developer
- SET Technology
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, RNA Therapeutics → Nucleic Acid Therapeutics
01
Overview
Dengue Virus Vaccine (SET Technology) is a DNA/RNA-based vaccine candidate currently in preclinical development for the prevention of Dengue Virus infection. Developed by SET Technology using their proprietary platform, the vaccine is designed to deliver genetic sequences encoding specific dengue virus antigens into host cells. This process triggers the production of viral proteins, which then stimulate the immune system to generate a protective response, including the production of neutralizing antibodies and T-cell activation. The goal of the program is to provide an effective immunization strategy against the dengue virus using advanced nucleic acid delivery technology.
- Other names
- Dengue Virus Vaccine
02
Targets
TLR3 (Toll-like receptor 3)
Beyond the preview
Go deeper on Dengue Virus Vaccine (SET Technology).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dengue Virus Vaccine (SET Technology).